Victor Brand

Victor Brand is a Research Fellow at the Department of Radiation Oncology, Erasmus Medical Center, Erasmus University Rotterdam. His work focuses on advanced radiotherapy techniques for prostate cancer treatment, with particular expertise in hypofractionated radiotherapy, stereotactic body radiation therapy, and neurovascular bundle sparing.

Dr. Brand's research interests center on optimizing prostate cancer radiotherapy while minimizing side effects. His work explores seminal vesicle motion during treatment, neurovascular bundle sparing techniques, and toxicity patterns in hypofractionated regimens. He employs systematic reviews, meta-analyses, and clinical trials to advance evidence-based practices in radiation oncology.

His publication record demonstrates a consistent focus on improving precision in prostate cancer radiotherapy. Recent work examines challenges in neurovascular bundle sparing, treatment uncertainties in hypofractionated regimens, and innovative approaches like online adaptive robotic stereotactic body radiation therapy for high-risk patients. His research bridges technical radiation physics with clinical outcomes to enhance patient care.

• Prostate Cancer Medicine and Dentistry (100%)
• Radiation Therapy Medicine and Dentistry (85%)
• Seminal Vesicle Medicine and Dentistry (63%)
• Hypofractionated Radiotherapy Medicine and Dentistry (63%)

Dr. Brand actively collaborates with leading researchers including M.S. Hoogeman, L. Incrocci, and M.T.W. Milder. His work has been cited multiple times, with his 2022 review on seminal vesicle motion receiving 21 Scopus citations. His research has garnered attention on social media platforms and academic networking sites, with multiple mentions on X and readership on Mendeley.